Ernest R Camp Selected Research

Ernest R Camp Research Topics

4	Neoplasms (Cancer) 01/2020 - 09/2005
2	Neoplasm Metastasis (Metastasis) 10/2007 - 09/2005
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Dyslipidemias (Dyslipidemia) 04/2013
1	Diabetes Mellitus 04/2013
1	Hypertension (High Blood Pressure) 04/2013
1	Colonic Neoplasms (Colon Cancer) 04/2013
1	Carcinoma (Carcinomatosis) 10/2007
1	Colorectal Neoplasms (Colorectal Cancer) 10/2007
1	Esophageal Neoplasms (Esophageal Cancer) 05/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2005

2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 05/2006
2	Monoclonal AntibodiesIBA 10/2007 - 09/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2007 - 09/2005
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2007 - 09/2005
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2013
1	Insulin (Novolin)FDA Link 04/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2007
1	NF-kappa B (NF-kB)IBA 05/2006
1	NF-KappaB Inhibitor alphaIBA 05/2006
1	Docetaxel (Taxotere)FDA Link 05/2006
1	Urokinase Plasminogen Activator ReceptorsIBA 09/2005
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2005
1	Gemcitabine FDA Link 09/2005
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2005

4	Therapeutics 01/2020 - 09/2005
1	Neoadjuvant Therapy 01/2020
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 04/2013
1	Treatment Delay 10/2007
1	Drug Therapy (Chemotherapy) 05/2006